Methods: Two protocols were performed, a hyperinsulinaemic-euglycaemic clamp and a normoinsulinaemic normoglycaemic protocol, in awake control and insulin-resistant fructose-fed rats. The tracer was injected at steady state, and activity in 11 tissues and the blood were assessed ex vivo at several time points. A multicompartmental mathematical model was developed to obtain fractional transfer coefficients of 6DIG from the blood to the organs.
Introduction
The dramatic worldwide increase in the prevalence of type 2 diabetes represents a major health problem [1] . A major feature of type 2 diabetes is that the pathology usually remains undiagnosed for as long as 9-12 years [2] , a period of time during which insulin resistance, mostly characterised by an impairment in insulin-stimulated glucose transport, progressively occurs in the skeletal muscle, myocardium and adipose tissue [3] [4] [5] . Insulin resistance is the best predictor of the future development of type 2 diabetes and probably plays a major role in its pathogenesis [6, 7] . Several methods have been proposed for the in vivo quantification of global insulin action through dynamic interventions or steady-state assessment, the gold standard remaining the hyperinsulinaemic glucose clamp [8] . However, the complexity and length of this technique render it unsuitable for routine clinical use. Moreover, it appears that tissue-specific, metabolite-specific and process-specific responses can occur, which cannot be assessed using a global measure of insulin resistance such as that provided by the hyperinsulinemic glucose clamp technique [8] .
Nuclear Medicine has the potential to provide a suitable means of assessing regional insulin resistance in a non-invasive manner using appropriate radiolabelled tracers. The most common approach is the physiological modelling of dynamic positron emission tomography (PET) imaging using 18 F-2-fluoro-2-deoxy-D-glucose (FDG), which enters the cell through glucose transporters (GLUTs) and is then phosphorylated by the hexokinase [9, 10] . FDG has been used to assess impairment of glucose transport and phosphorylation in human skeletal muscle, in myocardium and in adipose tissue [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] . However, the emission from 18 F reflects both 18 F-FDG and 18 F-FDG-6-phosphate, which leads to uncertainty as to whether compartmental modelling achieves separate estimations of glucose transport and phosphorylation. To isolate the HAL author manuscript inserm-00262409, version 1 step of transmembrane glucose transport, dynamic PET imaging of 11 C-3-O-methyl-D-glucose (3-OMG) has been proposed [21] . 3-OMG is a glucose analogue which is also transported into the cell through GLUTs. Unlike FDG, 3-OMG is not further metabolised, and its transport across the cellular membrane is therefore bi-directional [22, 23] . The cellular uptake of 3-OMG allows true glucose transport rates to be determined. 3-OMG has been used in humans to study regional glucose transport in the brain, the heart [24, 25] and, more recently, the skeletal muscle [21] .
However, the use of this tracer is limited by the fact that it is labelled with a very short half-life radioisotope ( 11 C, t 1/2 =20 min), which undoubtedly explains why very few studies have been devoted to this compound and excludes routine clinical use. 14 C-labelled 3-OMG has been used in vivo to identify glucose transport defects in the skeletal muscle of patients with type 2 diabetes [26] [27] [28] . However, 14 C is a β-emitter that does not allow in vivo imaging. Moreover, its long halflife precludes its use in clinical practice.
123 I-6-deoxy-6-iodo-D-glucose (6DIG) is a radiolabelled tracer of glucose transport that was previously described by our laboratory and proposed as an alternative tracer to assess insulin resistance in vivo [29] . The biological behaviour of 6DIG is similar to that of 3-OMG [30] . An in vitro study on adipocytes from diabetic rats and obese mice showed that 6DIG, like 3-OMG, could be used to determine alterations in glucose transport [31] . Finally, an in vivo study in diabetic db/db mice showed that 6DIG was able to identify defects in glucose transport associated with the presence of type 2 diabetes [32] . However, the ability of 6DIG to identify the more clinically relevant pre-diabetic state of insulin resistance has not yet been evaluated. The hypothesis tested in the present study was that 6DIG would allow the identification of variations in glucose transport in such pre-diabetic model. Steady-state, well-controlled euglycaemic and hyperinsulinaemic conditions were obtained and mathematical modelling was used to HAL author manuscript inserm-00262409, version 1 discriminate between non-diabetic, insulin-resistant rats and control rats. This study sets the stage for the future use of 6DIG as a non-invasive means for the evaluation of insulin resistance.
Materials and methods

Biological Material
Animals were provided by Iffa Credo (Les Arbresles, France), diets by UAR (Lyon, France), 
Synthesis and labelling of 6DIG
6DIG was obtained as previously described [33] . Since the labelled glucose was stable for at least 1 month as determined by high-performance liquid chromatography (data not shown), 125 I (t 1/2 =60 days) labelling was used for this study instead of 123 I (t 1/2 =13 h) to avoid repetitive labelling of the compound. The radiolabelling of 6DIG was performed by 125 I -127 I isotopic exchange according to a previously described method [32] .
Biological Procedure
Animals. Ninety-six male Wistar rats weighing about 50 g (3 weeks old, just after weaning) were housed (five animals/cage) in an environmentally controlled room with a 12-h light/dark cycle and free access to laboratory diet and water. The animals were divided into two groups: the control group received a standard UAR 210 diet (n=48) and the fructose-fed group received the UAR 210 "fructose" diet (n=48) in which fructose composed 56.8% of total carbohydrates [34, 35] . The rats were numbered and their body weight was monitored weekly for 6-7 weeks.
Protocols. All rats were catheterised in the jugular vein and the carotid artery as previously described and studies were conducted 24 h thereafter in the fasting and unrestrained conscious Samples from the blood, heart, diaphragm, lungs, liver, duodenum, kidneys, abdominal fat, epididymal fat, quadriceps muscle and brain (cortex) were rapidly obtained. For reasons of clarity, only data from the blood, heart, diaphragm, quadriceps muscle, abdominal fat and lungs will only be presented, but all organs were taken into account for the development of the mathematical model (see below). The organs were rinsed, weighed, and the radioactivity was assessed as described below.
Calculations. At high levels of insulin infusion, the rate of glucose disappearance from the blood (Rd) can be determined by the GIR. Since previous experiments in our laboratory have shown that in similar experimental conditions in an identical animal model, hepatic glucose production was totally inhibited by insulin [36] , the GIR obtained in our study reflected the insulin 
Mathematical Material
The software SAAM II (Simulation, Analysis And Modeling) was used to develop a compartmental model and the associated differential equations to perform parameter estimation and to fit to the data.
Mathematical Procedure
Mathematical model. The model developed to assess 6DIG transport was a multicompartmental, mamillary model derived from the one used to define the total body distribution kinetics of FDG [37] . It was used to fit the behaviour of the tracer following injection in rats in vivo. The central compartment represented the plasma (q 1 ) in which the tracer was injected and from which an irreversible loss occurred (k 0,1 ) [38] . This compartment had bi-directional and linear flux with 11 compartments, which represented the studied organs, q 2 to q 12 . Radioactivity was measured in these compartments, labelled s 1 to s 12 respectively (Fig. 2) .
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where k ij is the fractional rate of transfer of the tracer from compartment j to compartment i (j ≠ i). Measurement error was assumed to be additive, uncorrelated and zero mean.
Experimental measurements were obtained at precise times (2, 3, 5, 7, 10, 15 and 20 min p.i.) and represented a theoretical output sampling of the model. For biological systems, the knowledge of the noise induced by experimental errors is limited. However, it is generally accepted that the noise is additive and zero mean, that measurement errors are independent and that the noise follows a Gaussian distribution [38, 39] .
Overall identification of the system. The structural identification defines the theoretical aspect of model identification; it verifies the number of acceptable solutions by the equation system describing the model and the measurements performed [40] . It consists in the resolution of a nonlinear algebraic equation system, which increases in number of terms and degrees of nonlinearity with the model order. In the present study, the volume of the blood compartment (V) and the weight of the organs (m 2 , m 3 ,..., m 12 ) were fixed to obtain a unique identification of the transfer parameters k ij of the model [40, 41] .
Numerical identification. Parameters were estimated on the basis of the assumption that the radioactivity measurements are described by: z(t i ) = y(t i ) + e(t i ) i = 1..., N, where e represents the measurement error and N is the number of time measurements (N = 7). Measurement error was assumed to be additive, independent and zero mean: e = 0 . The mathematical model was applied HAL author manuscript inserm-00262409, version 1 to the experimental data using SAAM II software and enabled indirect quantification of the physiological parameters, the fractional transfer coefficients (k ij ) not being accessible directly. 
Precision of parameters.
Results
Characteristics of control and fructose-fed animals
The results are depicted in Table 1 . The "fructose" diet had no effect on the mean body weight of rats. Fasting glycaemia was not significantly different in control and fructose-fed rats 
Biodistribution of 6DIG
Figures 3 and 4 depict the biodistributions of 6DIG in control and fructose-fed rats respectively, in basal conditions (panels a) and in euglycaemic-hyperinsulinaemic conditions (panels b). The results indicated that circulating 6DIG activity decreased from 2 to 20 minutes following tracer injection. The blood kinetics of the tracer were similar in the absence or in the presence of insulin in both experimental groups (Table 2 ). In the non-insulin-sensitive organs studied, the evolution of 6DIG activity was comparable to that observed in the blood and no significant difference was observed during insulin clamp. Regarding insulin-sensitive organs, in the heart and the diaphragm of control and fructose-fed rats there was a frank and significant increase of 6DIG activity at early time points following perfusion of insulin although the difference was less dramatic in fructose-fed rats (Figs. 3, 4 ). This effect of insulin was also observed in a kinetic point of view (p<0.001 and p<0.01 for the heart and diaphragm in control rats, respectively; p<0.05 and p=NS for the heart and diaphragm in fructose-fed rats, respectively) ( Table 2) . A particular behaviour was observed in the skeletal muscle, in which 6DIG radioactivity increased with time, from 0.17±0.03 %ID/g to 0.24±0.02 %ID/g in control rats ( Fig. 3a) and from 0.15±0.01 %ID/g to 0.28±0.02 %ID/g in fructose-fed rats (Fig. 4a) . A significant increase of 6DIG activity under insulin clamp was observed in skeletal muscle but in a HAL author manuscript inserm-00262409, version 1 less extend and at later time points than in the heart and diaphragm (Figs. 3, 4) . The effect of insulin was also observed on the muscle 6DIG kinetics (p<0.05 in control rats and p=NS in fructose rats) ( Table 2 ). In the abdominal fat of control and fructose-fed rats, 6DIG radioactivity was very low, less than 0.1 %ID/g in both conditions.
Mathematical modelling
Compartmental analysis of 6DIG kinetics. The 6DIG kinetics obtained in the blood and organs were analysed using the multicompartmental model shown in Fig. 2 . Compartment 1 represented the distribution volume of the tracer immediately after injection. It was assumed to be equal to the blood volume, which represents 4 ml/100 g of body weight in the rat [42, 43] . The elimination of 6DIG from the body was considered as an irreversible flux from compartment 1 (k 0,1 ), whereas the exchanges of 6DIG between compartment 1 and the other compartments (q 2 to q 12 ) were represented by the rate constant into (k ij ) and out of (k ji ) the compartment (Table 3) .
These parameters were estimated after adjustment of the model to the experimental data. All the model parameters were estimated with good precision (coefficients of variation <100 %).
Representative examples of the adjustment of the model to the experimental data for insulinsensitive organs of control and fructose-fed rats are shown in Figs. 5 and 6, respectively. Figure 7 presents the adjustment of the model for the plasma of control animals. It can be concluded from the results that the model correctly fitted the data and that it was therefore adequate for describing 6DIG transport kinetics. The evaluation of residual errors for the 6DIG kinetics in insulinsensitive organs and plasma of control rats is represented in Figs. 8 and 9 , respectively. The residues were well distributed around zero, indicating that the model was adequate for the description of the 6DIG experimental data. Moreover, the average residues were below 0.2% for HAL author manuscript inserm-00262409, version 1 insulin-sensitive organ and below 0.6% for plasma. Their distribution was random and followed a normal law (data not shown).
Comparison between sham-operated and insulin clamp conditions in control rats.
The results are presented in Table 3 . In the presence of insulin, the irreversible flux (k 0,1 ) was significantly decreased by 28%, from 0.329 (18%) min -1 during the sham-operated protocol to 0.236 (6%) min -1 during insulin clamp (p<0.05). The fractional transfer coefficients of 6DIG
from the blood into insulin-sensitive organs were significantly increased in the presence of insulin. Specifically, k 2,1 (heart), k 3,1 (skeletal muscle) and k 4,1 (diaphragm) were respectively increased 5-fold (p<0.01), 3.5-fold (p<0.001) and 2.5-fold (p<0.001) during the insulin clamp protocol. No significant increase in 6DIG transport was observed in the adipose tissue in the presence of insulin. The fractional transfer coefficients out of the organs were also significantly increased. k 1,2 (heart), k 1,3 (skeletal muscle) and k 1,4 (diaphragm) were respectively increased 3.7-fold (p<0.05), 3.5-fold (p<0.01) and 2.7-fold (p<0.05) during the insulin clamp protocol. In noninsulin-sensitive organs, insulin had no significant effect on 6DIG fractional transfer coefficients. (Table 3 ). In the presence of insulin, the irreversible flux (k 0,1 ) was significantly decreased by 30% in fructose-fed rats, from 0.214 (6%) min -1 in sham-operated protocol to 0.149 (18%) min -1 during the insulin clamp (p<0.05). In insulin-sensitive organs, insulin had only a slight effect on the 6DIG transport into and out of the organs, which was not significant in most of these organs.
Comparison between sham-operated and insulin clamp conditions in fructose-fed rats
As an example, the fractional transfer coefficients of 6DIG in the heart (k 2,1 and k 
Discussion
Insulin resistance is primarily characterised by a defect in glucose transport following insulin stimulation. This phenomenon has been observed in numerous pathological disorders such as type 2 diabetes, cardiovascular disease (syndrome X) and obesity [5, 44] . 6DIG is a radiolabelled tracer of glucose transport which has a biological behaviour similar to that of 3-OMG and has been proposed for the assessment of insulin resistance in vivo by nuclear imaging [30] [31] [32] . The ability of 6DIG to identify the more clinically relevant pre-diabetic state of insulin resistance has not yet been determined. Accordingly, the present study was performed in an animal model, the fructose-fed rats [34, 35] . The main finding of this study is that kinetics of 6DIG allowed the identification of moderately insulin resistant animals and mathematical modelling made it possible to obtain numerical parameters. The heart was the organ in which insulin had the most important effect, with a difference potentially sufficient to be detected by non-invasive nuclear imaging in vivo and quantified with an adapted model.
In control and fructose-fed animals, the kinetics of 6DIG were performed during the steady-state of a sham and an euglycaemic-hyperinsulinaemic clamp protocol. This last method allowed us (1) to directly and independently assess insulin resistance through the measurement of the GIR and (2) to reach steady state conditions necessary to evaluate the kinetics of 6DIG in the setting of hyperinsulinaemia and normoglycaemia. Our data showed that insulin resistance of fructose-fed rats, reflected by a GIR 40% lower than that of the control rats, was associated with compensatory hyperinsulinaemia at baseline, a typical feature of the pre-diabetic state, whereas HAL author manuscript inserm-00262409, version 1 baseline glycaemia was not significantly different. During insulin clamp, the plasma insulin concentration increased in control and fructose-fed animals to reach a comparable value of ~1,300 pmol/l whereas the glycaemia did not change. In both conditions and both groups of rats, 6DIG radioactivity evolution in most of the organs was identical to that observed in the blood.
These results are comparable to those obtained in wild type db/+ mice, supporting the fact that 6DIG, a non-phosphorylable glucose transport tracer, reaches an equilibrium between the blood and tissues [32] .
Given the particular behaviour of 6DIG, which rapidly reaches equilibrium between the plasma and extra-and intracellular spaces, we developed a mathematical model to quantify the inward and outward transfer rates of the tracer in each organ. This mathematical model, well adapted and applied to the kinetic values, enabled us to quantify the physiological parameters (k)
which cannot be measured directly. The model chosen for the study was multicompartmental, mamillary and linear. This model is relatively simple because of the limited number of points, provided a good fit to the data and led to good estimation of the model parameters (k ij ). The central compartment is supposed to represent the plasma, but it actually represents a pool where very fast exchanges between plasma and the erythrocytes occur [45] . In our model, we did not take into account these flows of matter, which are extremely fast, and we rather focused on flows between plasma and the intracellular compartments of the 11 organs studied, which have slightly slower kinetics. It is important to point out that this model was used with a specific aim, namely to measure fractional amounts of the tracer entering and leaving the various tissue compartments.
The extracellular compartments are supposed to be included in the compartment "organ"; thus each compartment body contains both the extra-and the intracellular spaces. Such a constraint was imposed on the model for reasons of numerical identifiabilities [41] . Indeed, if the extracellular space is separated from the intracellular space for each organ, there is an additional [31] . The most interesting feature of the model is its application to a large number of organs in addition to the blood. It was also the most suitable model for our study both for the structure and the estimation of parameters. The coefficients of variation were slightly high because of the restricted number of animal studied. However, they were sufficient to detect significant differences between groups.
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In control rats, the loss represented by ( in vitro that insulin increased 6DIG transport in adipocytes isolated from both rats and mice and that this stimulation was greater in rat than in mouse adipocytes, in agreement with their respective number of GLUT4 transporters [31] . The discrepancy between the in vivo and in vitro action of insulin on 6DIG activity in the adipose tissue has also been reported for 2-DG, a tracer of glucose transport and phosphorylation [46] . The low uptake of 6DIG and 2-DG observed in vivo could be due to the poor vascularisation of this tissue. Moreover, James et al. calculated that the increase in white adipose tissue glucose utilisation during hyperinsulinaemia for a 400-g rat with 15-20% body fat represented at most only 3% of the whole-body GIR [46] . This and the relatively low level of hyperinsulinaemia are probably the reasons why we were unable to see any changes in 6DIG activity in the adipose tissue during the insulin clamp protocol.
In both conditions and for both groups of rats, skeletal muscle kinetics differed markedly from those observed in other organs, and the adjustment of the model to the experimental data obtained in this organ was suboptimal. Indeed, 6DIG uptake increased slightly between 2 and 7 min and then reached a plateau until 20 min. While 6DIG was quickly eliminated from the other organs, it therefore seemed to be retained in the skeletal muscle. This retention has also been recently observed in vivo in human with PET imaging of the glucose transport tracer 11 C-3OMG [21] . This suboptimal result could be explained by the fact that the multicompartmental model used in the present study is based on the assumption that all tissue kinetics are similar. Moreover, Saccomani et al. and Bonadonna et al. had to develop a very complex model to measure glucose transport in skeletal muscle with tracers owing to the heterogeneity of this tissue [45, 3] . Skeletal muscle is quantitatively the most important glucose-utilising tissue, accounting for 70-80% of glucose utilised during hyperinsulinaemia, and is the principal site of insulin resistance [48] .
Most experiments using radioactive tracers to study glucose transport stimulated by insulin in vivo have been performed on human forearm or leg muscles [3, 11-14, 16, 17, 25-28] . Therefore, further additional studies are currently underway to fully characterise 6DIG kinetics in this particular organ.
Our aim was to identify glucose transport variations in vivo with 6DIG to allow further discrimination between control and insulin-resistant rats. In our conditions, the heart and the diaphragm were the organs in which insulin had the most important effect on the model parameters. Indeed, after 2 min, 6DIG uptake in the heart doubled and k 2,1 was multiplied by 5 whereas k 1,2 showed only a threefold increase, and in the diaphragm, k 4,1 was multiplied by 2.5.
However, the size of this last organ precludes it as a target for imaging. Nevertheless, the differences observed in the heart are theoretically sufficient to be detected by nuclear imaging in vivo and to be quantified with a suitable adapted model. In fructose-fed rats, insulin had only a slight effect on the 6DIG transport into and out of the organs, which was not significant in most organs, whether they were insulin sensitive or not.
In conclusion, the present study has shown for the first time that it is possible to identify variations of glucose transport in vivo in a pre-diabetic animal model using the glucose transport tracer 6DIG. However, further studies are needed to determine whether non-invasive nuclear imaging of 6DIG in the heart will allow the discrimination of control and insulin-resistant animals. In this setting, the greater number of experimental time points provided by non-invasive imaging should allow superior temporal resolution and therefore excellent numerical estimation of the model parameters. 
